Nascent Biotech Inc. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q2 2014 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Nascent Biotech Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q2 2014 to Q2 2024.
- Nascent Biotech Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending June 30, 2024 was -$325K, a 99.6% decline year-over-year.
- Nascent Biotech Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$1.19M, a 33.6% increase from 2022.
- Nascent Biotech Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$1.79M, a 532% decline from 2021.
- Nascent Biotech Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was $413K.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)